Neurosoft Bioelectronics

📍 Geneva, Switzerland🗓 Founded 2020👥 20 employees💰 Last funded Mar 2025
At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Japan
1
Frequently asked questions
Who invested in Neurosoft Bioelectronics?
Neurosoft Bioelectronics has 1 investors on record on gritt.io, 1 mid-stage.
When did Neurosoft Bioelectronics last raise funding?
The most recent investment in Neurosoft Bioelectronics recorded on gritt.io was in March 2025.
When was Neurosoft Bioelectronics founded?
Neurosoft Bioelectronics was founded in 2020.
What industry is Neurosoft Bioelectronics in?
Neurosoft Bioelectronics operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Neurosoft Bioelectronics based?
Neurosoft Bioelectronics is headquartered in Geneva, Switzerland.